Hemophilia

Latest News

Hemgenix Gene Therapy Shows Long-Term Efficacy, Safety in Hemophilia B Patients
Hemgenix Gene Therapy Shows Long-Term Efficacy, Safety in Hemophilia B Patients

December 21st 2023

Men with severe or moderately severe hemophilia B continue to display low bleeding rates and very little use of replacement therapies for at least three years following a single dose of the approved gene therapy hemgenix.

imageflow-stock.adobe.com
FDA Sets Review Date for Marstacimab to Treat Hemophilia

December 12th 2023

FDA Approves Adzynma for Rare Blood Clotting Disorder cTTP
FDA Approves Adzynma for Rare Blood Clotting Disorder cTTP

November 27th 2023

Study Highlights Poor Health Outcomes in Older Adults with Hemophilia
Study Highlights Poor Health Outcomes in Older Adults with Hemophilia

November 24th 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.